touchLearning Activities
Education, Conference Coverage and Articles
EASD President Francesco Giorgino previews EASD 2026, discussing the key developments set to shape diabetes research and care, including incretin therapies, type 1 diabetes, AI and diabetes technology, personalized care, screening, and his priorities for EASD during his presidency.
Meet the endocrinologists shaping the future of the specialty. The touchENDOCRINOLOGY Future Leaders 2026 are rising stars nominated by the endocrinology community for their contributions to research, clinical practice and innovation. Discover the clinicians and researchers challenging convention, advancing care and driving progress across endocrinology.
Dr Maria Martinez-Cruz is a physician-scientist and touchENDOCRINOLOGY Future Leader 2026. In this interview, she discusses cardiometabolic research, the mentors who shaped her career, balancing clinical practice and research, and her vision for inspiring the next generation of physician-scientists.
Dr Rossella Cannarella discusses her journey in endocrinology, the role of mentorship, and her research in male infertility, reproductive endocrinology and sperm epigenetics, sharing advice for future generations.
We are delighted to announce Dr Stefano Passanisi as a touchENDOCRINOLOGY Future Leader 2026, recognized by peers as an emerging leader in pediatric endocrinology. Dr Stefano Passanisi is a pediatrician and clinical researcher at the University Hospital of Messina, Italy. Working ...
Dr Stéfanie Parisien-La Salle discusses her path into endocrinology, the mentors who shaped her career, her passion for adrenal research, and how research continues to inform patient care.
In this touchENDOCRINOLOGY Future Leaders 2026 Q&A, Dr Simon Berry (Sheffield, UK) reflects on the experiences that led him into diabetes and endocrinology, the mentors who have influenced his clinical and academic journey, and the innovations he believes are set to transform patient care. From advances in immunotherapy and islet transplantation to the evolving landscape of diabetes treatment, Simon shares his perspectives on the opportunities ahead for the specialty.
We are delighted to announce Dr Rimesh Pal as a touchENDOCRINOLOGY Future Leader 2026, recognized by his peers as an emerging leader in endocrinology and metabolic bone research. Dr Rimesh Pal is Associate Professor of Endocrinology at the Postgraduate Institute of ...
In this touchENDOCRINOLOGY Future Leader 2026 Q&A, Dr Qilin Zhang reflects on the experiences that have shaped his career across endocrinology, neurosurgery, and translational research. He discusses collaboration, balancing clinical and academic priorities, and how precision approaches are helping redefine the future of pituitary tumor management.
Dr Mindy Lee discusses mentorship, patient-centred care and the potential of diabetes technology to improve outcomes, sharing how clinical experiences inspire innovative, equitable solutions for children and young people.
Recognized as a touchENDOCRINOLOGY Future Leader 2026, Dr Leen Antonio discusses mentorship, research, and the role of clinician-scientists in advancing evidence-based endocrine care.
We are delighted to announce Dr Jonathan Mertens as a touchENDOCRINOLOGY Future Leader 2026, recognized for his emerging contributions to diabetes, metabolic health and translational endocrinology research. Dr Jonathan Mertens is an endocrinologist and researcher at Antwerp University Hospital and the ...
Dr Hironori Bando discusses the mentors who shaped his career, the rewards of supporting young researchers, and how research can deepen clinical insight and improve patient care.
Dr Georgia Colleluori discusses her journey into endocrinology, key career milestones in obesity and metabolism research, and the value of diverse experiences in shaping the next generation of researchers.
touchENDOCRINOLOGY Future Leaders 2026 is almost here! We are counting down to the launch of our annual celebration of the rising stars shaping the future of ENDOCRINOLOGY. Nominated by the global endocrinology community, these exceptional early-career clinicians and researchers have demonstrated outstanding promise through their contributions to clinical practice, research, education and leadership. Discover the inspiring individuals driving innovation and helping define the next generation of endocrinology care.
Topline data from the TRIUMPH-2 and TRIUMPH-3 trials show substantial weight loss, improved glycemic control, and favorable changes in cardiometabolic risk markers with the investigational triple hormone receptor agonist in adults with obesity and type 2 diabetes or established cardiovascular disease.
A new Endocrine Society statement has reinforced the importance of accurate diagnosis and appropriate clinical assessment before testosterone replacement therapy (TRT) is initiated in men with hypogonadism.1 Published July 16, 2026, the statement reiterates that treatment should not be based on symptoms alone and highlights continuing uncertainties around the long-term safety of TRT. It follows an FDA expert panel that reviewed testosterone eligibility criteria in December 2025, Society comments submitted to the FDA in February 2026, and new prescribing-pattern data presented at ENDO 2026, the Society's annual meeting, in June.
touchENDOCRINOLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
